RET-31221-75562
4 vaccinations
3 coded responses
43 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 537 / WI
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 1 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-10
- 2021-01-14
- 2021-01-16
- 2021-01-28
-
2021-01-30
Dose 2 — Pfizer-BioNTech
- 2021-01-30
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Abdominal painAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Abdominal painAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-02-16
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-14
- 2021-05-01
- 2021-07-31
-
2021-10-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
-
2022-01-04
Survey response — 3 months, dose 3MedDRA: Cough, Fatigue, Headache, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold symptoms- coughing, sore throat, congestion, runny nose, fatigue, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-04-06
-
2022-09-27
Dose 4 — Pfizer-BioNTech
-
2022-09-27
Health check-in — day 0, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2022-09-28
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-09-29
- 2022-10-01
- 2022-10-02
- 2022-10-04
- 2022-10-12
-
2022-10-18
Survey response — day 21, dose 4MedDRA: Alopecia, Brain fog, Fatigue, Post-acute COVID-19 syndrome — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fatigue, brain fog, and hair loss (likely due to long COVID)MedDRA releases: 2024-11 · check-in free text available
- 2022-10-25
- 2022-11-01
- 2022-11-10
-
2022-12-27
Survey response — 3 months, dose 4MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pregnancy and resulting side effectsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Pfizer-BioNTech | |
| 2 | 2021-01-30 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-27 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 3
Symptoms: Cold symptoms- coughing, sore throat, congestion, runny nose, fatigue, headache
Release 12 — day 21, dose 4
Symptoms: Fatigue, brain fog, and hair loss (likely due to long COVID)
Release 12 — 3 months, dose 4
Symptoms: Pregnancy and resulting side effects
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alopecia | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release